Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2026-08-10 21:35:04 ET · period of report 2026-08-06 · accession 0001193125-26-343073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 21:35 | 2026-08-06 | APVO | Huebner Dirk | SVP, CMO | M - OptEx | — | +638 | 638 | New | — |
| D | 2026-08-10 21:35 | 2026-08-06 | APVO | Huebner Dirk | SVP, CMO | F - Tax | $4.07 | -156 | 482 | -24% | -$634.92 |
| D | 2026-08-10 21:35 | 2026-08-06 | APVO | Huebner Dirk | SVP, CMO | M - OptEx | $0.00 | -638 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-06 | M | A | 638 | — | 638 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-08-06 | F | D | 156 | $4.07 | 482 | D | — | — | (F2) Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs. |
| 3 | Derivative | Restricted Stock Unit | 2026-08-06 | M | D | 638 | $0.00 | 0 | D | — · — to — | 638 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant. (F3) On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant. |